I am a founding partner of Westerberg and joined the team in 2008 from another law firm, before we formed Westerberg in 2019.
I am an experienced lawyer with a keen and firm interest in the sectors within which I work. I maintain a high degree of personal attention to matters, and I believe in straightforward communication with clients. The team and I are one of few regulatory groups in Sweden.
I have worked with Life Sciences and related highly-regulated sectors such as alcohol, tobacco, foodstuffs and chemicals since 2002, covering all regulatory matters and commercial contract issues, with a particular focus on market access, including pricing and reimbursement and related negotiations, classification and regulatory litigation. I also do a fair bit of product safety and product liability outside the above-mentioned sectors. A significant part of my work further relates to IP commercial matters within my areas of expertise, such as IP-focused transactions.
Recent work highlights include negotiating several acquisitions of multijurisdictional product portfolios of OTC brands and hygiene products for a Swedish client. I have also worked a great deal on matters relating to healthcare apps, such as classification and implementation, as well as patient data issues.
I am co-managing partner of Conférence Bleue, a leading network of European law firms specializing in pharmaceutical, health-care and medical regulatory law. I am also a member of DIA (Drug Information Association).
I regularly provide content to newsletters and magazines.
Examples of recent recognition include the following:
Listed by Who’s Who Legal for Life Sciences Regulatory, Transactions and Product Liability
Referred to in IAM Patent 1000 (2021) as a person who “pairs his encyclopaedic knowledge of regulatory law with a resolutely commercial outlook to draft contracts that transform the sectors in which his patrons operate”